BURLINGTON, North Carolina , May 16, 2023 (press release) –
Patients and Providers in Oregon Region Will Gain Broader Access to
-
Labcorp andProvidence Health & Services –Oregon (Providence Oregon) have entered into an agreement forLabcorp to acquire select assets of Providence Oregon's outreach laboratory business - Providence
Oregon will maintain ownership of certain anatomic pathology and genomics outreach testing and hospital laboratories located inOregon - Transaction builds on more than 20-year relationship between the Providence family of organizations and
Labcorp
"Expanding our deep relationship with Providence allows us to create greater healthcare access, bring world-class diagnostic capabilities and ensure affordability of services for patients and providers," said
This transaction will build on the more than 20-year relationship between
When the transaction is closed, patients and providers will continue to have access to Providence Oregon facilities and will benefit from
"We are proud of the high-quality, community-based laboratory services Providence
The transaction is expected to close later in 2023 and is subject to customary closing conditions and applicable regulatory approvals. There will be no changes to operations or services at Providence
About
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements, including but not limited to statements with respect to the acquisition of select laboratory assets from Providence [Health & Services -
Each of the forward-looking statements is subject to change based on various important factors, many of which are beyond the company's control. These factors, in some cases, have affected and in the future (together with other factors) could affect the company's ability to implement the company's business strategy and actual results could differ materially from those suggested by these forward-looking statements. As a result, readers are cautioned not to place undue reliance on any of the forward-looking statements.
The company has no obligation to provide any updates to these forward-looking statements even if its expectations change. All forward-looking statements are expressly qualified in their entirety by this cautionary statement. Further information on potential factors, risks and uncertainties that could affect operating and financial results is included in the company's most recent Annual Report on Form 10-K and subsequent Forms 10-Q, including in each case under the heading RISK FACTORS, and in the company's other filings with the
View original content:https://www.prnewswire.com/news-releases/labcorp-and-providence-expand-strategic-laboratory-relationship-301825730.html
SOURCE
Labcorp Contacts: Media: Kim Arculeo - 336-436-8263, Media@Labcorp.com; Investors: Chas Cook -- 336-436-5076, Investor@Labcorp.com
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistribute or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.